Is angiotensin-converting enzyme inhibitor appropriate for contrast-induced nephropathy? A meta-analysis about this field. - Suppr | 超能文献

Is angiotensin-converting enzyme inhibitor appropriate for contrast-induced nephropathy? A meta-analysis about this field.

作者信息

Li Ximing, Li Tingting, Fu Naikuan, Hu Yuecheng, Cong Hongliang

出版信息

Int J Cardiol. 2012 Mar 22;155(3):486-8. doi: 10.1016/j.ijcard.2011.12.067. Epub 2012 Jan 20.

DOI:10.1016/j.ijcard.2011.12.067

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Is angiotensin-converting enzyme inhibitor appropriate for contrast-induced nephropathy? A meta-analysis about this field.

Int J Cardiol. 2012 Mar 22;155(3):486-8. doi: 10.1016/j.ijcard.2011.12.067. Epub 2012 Jan 20.

2

Effect of Angiotensin-Converting Enzyme Inhibitors in Contrast-Induced Nephropathy: A Meta-Analysis.血管紧张素转换酶抑制剂在造影剂诱导的肾病中的作用：一项荟萃分析。

Nephron. 2016;133(1):1-14. doi: 10.1159/000445167. Epub 2016 May 21.

3

[Pathogenesis and prognosis of contrast-induced nephropathy (CIN)].[造影剂肾病（CIN）的发病机制与预后]

Nihon Rinsho. 2011 Sep;69 Suppl 7:216-9.

4

Angiotensin converting enzyme inhibitors and contrast-induced nephropathy.血管紧张素转换酶抑制剂与造影剂肾病

Ren Fail. 2006;28(1):99-100. doi: 10.1080/08860220500461336.

5

Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.血管紧张素转换酶抑制剂作为对比剂肾病的一个危险因素。

Nephron Clin Pract. 2006;104(1):c20-7. doi: 10.1159/000093255. Epub 2006 May 9.

6

Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy after cardiac catheterization or percutaneous coronary intervention.血管紧张素转换酶抑制剂及其对心脏导管插入术或经皮冠状动脉介入术后对比剂肾病的影响。

Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):90-3. doi: 10.1016/j.carrev.2010.01.002. Epub 2010 Oct 20.

7

Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study.非急诊冠状动脉造影患者的肾脏安全性与血管紧张素II阻断药物：一项随机对照研究

Isr Med Assoc J. 2013 Nov;15(11):682-7.

8

Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study.卡托普利预防糖尿病患者造影剂肾病的随机研究。

Indian Heart J. 1999 Sep-Oct;51(5):521-6.

9

Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox.血管紧张素转换酶抑制剂是对比剂肾病预防的禁忌证吗？对这一悖论的综述。

Cardiovasc Ther. 2012 Oct;30(5):273-6. doi: 10.1111/j.1755-5922.2011.00299.x. Epub 2011 Aug 10.

10

Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.肾素-血管紧张素阻滞剂撤药与继续用药对接受心脏导管插入术的肾功能不全患者急性肾损伤发生率的影响：心脏导管插入术患者中血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂与对比剂诱导的肾病（CAPTAIN）试验结果

Am Heart J. 2015 Jul;170(1):110-6. doi: 10.1016/j.ahj.2015.04.019. Epub 2015 Apr 18.

引用本文的文献

1

Angiotensin-Converting Enzyme Inhibitors and Contrast-Associated Acute Kidney Injury After Coronary Angiography and Intervention.血管紧张素转换酶抑制剂与冠状动脉造影及介入术后对比剂相关急性肾损伤

Am J Cardiovasc Drugs. 2021 Sep;21(5):487-497. doi: 10.1007/s40256-020-00455-5. Epub 2020 Dec 28.

2

The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis.肾素-血管紧张素-醛固酮系统阻断药物对接受冠状动脉造影患者造影剂诱导的肾病的影响：一项荟萃分析。

PLoS One. 2015 Jun 17;10(6):e0129747. doi: 10.1371/journal.pone.0129747. eCollection 2015.

3

Measures used to treat contrast-induced nephropathy: overview of reviews.用于治疗对比剂诱导肾病的方法：系统评价概述。

Br J Radiol. 2013 Jan;86(1021):20120272. doi: 10.1259/bjr.20120272.